91ɫƵ Researchers Aiming to Rewrite How Brain Injuries are Evaluated and Treated
Milwaukee, June 25, 2025 – Traumatic brain injury (TBI) has traditionally been categorized as “mild, moderate, or severe” based on relatively crude criteria. Clinicians, researchers, and patients alike all recognize that this over-simplified system is inadequate for a complex neurologic condition such as TBI. Researchers at the 91ɫƵ (91ɫƵ) are playing a leading role in a global effort to create an improved framework for the characterization of TBI.
Several 91ɫƵ faculty recently contributed to the National Institutes of Health-National Institute of Neurological Disorders and Stroke (NIH-NINDS) TBI Classification and Nomenclature Initiative. These included Drs. Michael McCrea, Lindsay Nelson, and Timothy Meier from the 91ɫƵ Department of Neurosurgery and Dr. Danny Thomas, emergency medicine physician in the 91ɫƵ Department of Pediatrics. All were selected based on their national recognition as experts in TBI care and research.
Dr. McCrea, co-director of 91ɫƵ’s Center for Neurotrauma Research; head of 91ɫƵ’s Brain Injury Research Program; and one of the world’s foremost researchers in TBI, (pictured right), served on the Steering Committee for the NIH Initiative and is co-senior author of “,” published in the June issue of The Lancet Neurology.
The classification the group developed is a multidimensional framework with four main pillars: Clinical, Biomarkers, Imaging, and Modifiers (CBI-M). It moves beyond traditional categories by integrating multiple dimensions of injury assessment, including clinical assessments, blood-based biomarkers, advanced imaging techniques like CT and MRI, and modifiers such as pre-existing health conditions, socioeconomic status, and history of brain injury. Drs. McCrea, Nelson, and Meier all played a major role in the Working Groups that created the CBI-M framework; Dr. Nelson is also lead author on the from the Modifiers Working group that was recently published in the Journal of Neurotrauma.
“While current categories for TBI can still be helpful in early clinical treatment, they were established in 1974, and don’t take into account the many advances our field has achieved over the last 50 years such as precise neuroimaging and biomarkers in your blood that can confirm TBI,” said Dr. Nelson.
The traditional classification system – the Glasgow Coma Scale – limits the ability to capture the complexity and variability of TBI. For example, some patients with “mild” TBI may experience persistent symptoms, while others with “severe” TBI may recover more fully than expected. Dr. Meier noted, “the CBI-M framework addresses these discrepancies by offering a more nuanced and comprehensive assessment, leading to improved patient stratification and potentially better outcomes.”
“Many people living with TBI feel like mild, moderate, and severe doesn’t really match their experience of recovery,” said Dr. Thomas. “Some have reported feeling like symptoms of mild cases weren’t taken as seriously, while some with severe TBIs have said the term suggests there’s no hope for recovery at all.”
Dr. McCrea is proud of the role 91ɫƵ has played in this monumental movement, noting “adoption of the CBI-M framework is expected to enhance clinical decision-making, personalize treatment strategies, and improve the design and interpretation of clinical trials. While full integration into healthcare systems may take time, the framework represents a significant advancement in the field of neurotrauma care.”
Keep up with the latest news. Sign up for Newsroom Alerts.
Latest press releases, stories and resources.
91ɫƵ Media Contacts
The media relations team at 91ɫƵ is happy to assist in coordinating experts for interviews. Please reach out to us at:
media@mcw.edu
(414) 955-8764
Contact us